Webcast Name: The Role of Behavioral Medicine in Reducing Opioid Use
Expiration Date: October 31, 2024
Learning Objectives
Target Audience
The educational activity is directed to family medicine physicians, physician assistants and nurse practitioners who are registered with the DEA and who are eligible to prescribe all opioid analgesics, as well as non-prescribers who manage patients receiving opioid analgesic therapy, non-pharmacologic therapies, and nonopioid medication therapies for pain.
Accreditation
In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
American Medical Association (AMA)
The Cleveland Clinic Center for Continuing Education designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
American Nurses Credentialing Center (ANCC)
Cleveland Clinic Center for Continuing Education designates this enduring activity for a maximum of 2.0 ANCC contact hours.
American Academy of PAs (AAPA)
Cleveland Clinic Center for Continuing Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. Approval is valid until 10/31/2024. PAs should only claim credit commensurate with the extent of their participation.
Activity Director
Amy Zack, MD
Department of Family Medicine
Vice Chair of Education
Primary Care Institute
Cleveland Clinic
Cleveland, OH
Faculty
Robert Bales, MD
Department of Family Medicine
Primary Care Institute
Center for Behavioral Health
Neurological Institute
Cleveland Clinic
Cleveland, OH
Richard W. Rosenquist, MD
Chairman, Pain Management Department
Cleveland Clinic
Cleveland, OH
Pavan Tankha, DO
Medical Director, Center for Comprehensive Pain Recovery
Neurological Institute
Cleveland Clinic
Cleveland, OH
Reviewers
Deb Kangisser, PA-C
Director of Education of PA Services
OPSA and Clinical Affairs
Cleveland Clinic
Cleveland, OH
David Streem, MD
Department of Psychiatry and Psychology
Chief of Psychiatry
Medical Director, Alcohol and Drug Recovery Center
Cleveland Clinic Lutheran Hospital
Cleveland, OH
Cindy Willis, DNP
Senior Director Nursing Education
Nursing Institute
Cleveland Clinic
Cleveland, OH
Disclosure
In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), Cleveland Clinic Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty members have indicated that they may have a relationship which, in the context of their contribution, could be perceived as a potential conflict of interest.
To ensure mitigation of conflicts of interest, content was reviewed by a non-conflicted reviewer to ensure that it is not commercially biased, was fair-balanced, and is based on scientific evidence and/or clinical reasoning.
Robert Bales, MD |
ROMTech—Private Ownership or Partnership |
Richard Rosenquist, MD |
Mainstay Medical Limited—Advisor/Review Panel Participant |
The following faculty and reviewers have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:
Deb Kangisser, PA-C
David Streem, MD
Pavan Tankha, DO
Cindy Willis, DNP
Amy Zack, MD
Cleveland Clinic Center for Continuing Education and The France Foundation staff report no relevant financial relationships to disclose.
Acknowledgement
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.
Please see https://www.opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).